Start with the Vyta Health Assessment, symptoms, history, biomarkers and relevant diagnostics.
ADVANCED LONGEVITY THERAPEUTICS
Measured first. Selected carefully. Refined over time.
Advanced therapies can be useful tools—but they are not shortcuts and they are never one-size-fits-all. Vyta is developing a physician-led pathway that evaluates each option against the woman’s health data, goals, risks and response.
THE VYTA STANDARD
A therapy is considered inside a care plan—not outside one.
The catalog below is a transparent look at the kinds of therapies Vyta may evaluate as its advanced longevity program develops. A listing is not a recommendation, promise of access or substitute for medical care.
Clarify the goal, evidence, alternatives, contraindications and potential tradeoffs.
Use a therapy only when it fits the woman’s care—not because it appears on a product list.
Track response, side effects and meaningful outcomes; continue, refine or stop accordingly.
REFERENCE CATALOG
The landscape we are evaluating.
Every product currently listed in the Immortals Medicine public catalog is represented below in original, plain-language summaries. Some are established medicines; some involve specialty formulations or emerging longevity applications; some are designed for men and may not fit Vyta’s women-focused model.
Metabolic tools selected around the woman—not the trend.
These therapies may influence appetite, glucose handling, insulin sensitivity or cardiometabolic risk. Selection begins with diagnostics, symptoms, history and a clear clinical objective.
Tirzepatide — personalized dose
A dual-pathway GLP-1/GIP option used in individualized metabolic and weight-management care.
Semaglutide — personalized dose
A GLP-1 option that may support appetite regulation, glucose control and clinically appropriate weight management.
Wegovy® tablets
An oral GLP-1 presentation listed in the reference catalog; access and regulatory status require verification before use.
Zepbound® KwikPen®
A branded tirzepatide delivery format for eligible patients under prescriber supervision.
Foundayo® tablets
An oral GLP-1 presentation listed in the reference catalog; formulation and availability require clinical verification.
Metformin
An established glucose-lowering medication sometimes evaluated in broader metabolic and longevity strategies.
Acarbose
A prescription therapy that slows carbohydrate digestion and may reduce post-meal glucose excursions.
Jardiance®
An SGLT2 inhibitor with established uses in diabetes, heart failure and kidney disease for appropriate patients.
Brenzavvy®
An SGLT2 inhibitor used to improve glucose control in eligible adults with type 2 diabetes.
Restore function with context, consent and clinical oversight.
Hormonal and sexual-health therapies require an individualized view of symptoms, tissue health, medications, contraindications and personal goals.
Estradiol
A prescription estrogen option that may be used in carefully selected menopause and genitourinary care.
Bremelanotide (PT-141)
A prescription peptide that acts on pathways involved in sexual desire and arousal for eligible patients.
Daily tadalafil
A PDE5 inhibitor with established uses in erectile and urinary care; broader vascular applications remain clinician-led.
Men’s Sex Complex
A specialty combination listed in the reference catalog for male sexual function; not part of Vyta’s current women-focused pathway.
Promising mechanisms still require disciplined evaluation.
Interest in recovery, oxidative stress and age-related signaling is growing. Vyta’s standard is to distinguish biological plausibility from outcomes that are established in humans.
Sermorelin
A prescription analog that stimulates the body’s own growth-hormone release and requires appropriate testing and monitoring.
NAD+
A metabolic cofactor offered in injectable form by some clinics; longevity benefits in humans remain under investigation.
Glutathione
An antioxidant used in specialty wellness settings; route, goal and evidence should be reviewed with a clinician.
Visible aging belongs inside whole-person care.
Skin and hair concerns can reflect hormonal, nutritional and age-related change. Topical, oral and regenerative options should be chosen around health history and measured need.
Peptide Skin Complex
A specialty topical combining tretinoin, niacinamide, caffeine and copper tripeptide.
Women’s Skin Complex
A specialty topical listed with estriol, finasteride, tretinoin and niacinamide.
Tretinoin
A prescription retinoid with established use for acne and photoaged skin.
Men’s Hair Complex
A specialty minoxidil, finasteride and biotin combination listed for male-pattern hair loss.
Oral minoxidil
A prescription medicine sometimes used off label for hair growth with cardiovascular monitoring.
NOT A PRODUCT SHELF
The right question is not “What can I take?”
It is “What is appropriate for me—and how will we know whether it is working?”
Prescription and off-label decisions require a licensed clinician, a valid medical indication, informed consent, contraindication review and ongoing monitoring. Formulations, regulatory status and availability can change. Vyta’s final offerings will be determined by clinical governance, provider availability and applicable law.
THE PATH FORWARD